{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:55:33Z","timestamp":1778882133260,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"R\u00e9gion Nord-Pas de Calais"},{"name":"Minist\u00e8re de la Jeunesse, de l'Education Nationale et de la Recherche"},{"name":"Fonds Europ\u00e9ens de D\u00e9veloppement R\u00e9gional"},{"name":"Lille 2 University"},{"name":"FRI \u201cJ'innove\u201d","award":["(A1112007 N)"],"award-info":[{"award-number":["(A1112007 N)"]}]},{"name":"PRES Univ Lille Nord de France"},{"name":"Nord de France SATT Grants"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejmech.2014.10.053","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T15:32:02Z","timestamp":1413646322000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands"],"prefix":"10.1016","volume":"89","author":[{"given":"Marion","family":"Donnier-Mar\u00e9chal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Emmanuel","family":"Larchanch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Le Broc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Furman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Carato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3446","authenticated-orcid":false,"given":"Patricia","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.10.053_bib1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2014.10.053_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","article-title":"The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements","volume":"682","author":"Pal","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.10.053_bib3","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2014.10.053_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2014.10.053_bib5","doi-asserted-by":"crossref","first-page":"43156","DOI":"10.1074\/jbc.M112.380444","article-title":"The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones","volume":"287","author":"Hayashi","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S1092852900022641","article-title":"Antidepressant treatment of psychotic major depression: potential role of the sigma receptor","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ejmech.2014.10.053_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/ern.09.40","article-title":"Sigma-1 receptors in major depression and anxiety","volume":"9","author":"Kulkarni","year":"2009","journal-title":"Exp. Rev. Neurother."},{"key":"10.1016\/j.ejmech.2014.10.053_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0149-7634(02)00017-9","article-title":"Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity","volume":"26","author":"Maurice","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2014.10.053_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00019442-200512000-00005","article-title":"A\u00a0variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease","volume":"13","author":"Uchida","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejmech.2014.10.053_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/jpet.111.190868","article-title":"Compromising \u03c3-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-\u03baB\/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease","volume":"341","author":"Mori","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.10.053_bib11","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1021\/jm3011993","article-title":"The sigma 1 receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain","volume":"55","author":"Wunsch","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib12","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1021\/jm3007323","article-title":"Synthesis and biological evaluation of the 1-arylpyrazole class of \u03c3(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)","volume":"55","author":"D\u00edaz","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2005.11.011","article-title":"The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines","volume":"242","author":"Aydar","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2014.10.053_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2004-832680","article-title":"Clinical trials with sigma ligands","volume":"37","author":"Volz","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejmech.2014.10.053_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0269881110379286","article-title":"Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma 1 ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative","volume":"25","author":"Villard","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.ejmech.2014.10.053_bib16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau hyperphosphorylation and A\u03b21-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c3\u2081 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2014.10.053_bib17","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/j.bmcl.2005.07.040","article-title":"Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective \u03c31 ligands. Part 1","volume":"15","author":"Charton","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.10.053_bib18","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/j.bmcl.2005.07.039","article-title":"Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective \u03c31 ligands. Part 2","volume":"15","author":"Gassiot","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.10.053_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2009.10.004","article-title":"Sigma-1 ligands: Tic-hydantoin as a key pharmacophore","volume":"45","author":"Toussaint","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/157340610793563956","article-title":"New synthesis of tic-hydantoins sigma-1 ligands and pharmacological evaluation on cocaine-induced stimulant effects","volume":"6","author":"Toussaint","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.euroneuro.2009.01.008","article-title":"Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects","volume":"19","author":"Toussaint","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2014.10.053_bib22","article-title":"High affinity sigma1 receptor agonist attenuated experimental autoimmune encephalomyelitis","author":"Oxombre","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.10.053_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2174\/138955705774329519","article-title":"Pharmacophore identification for sigma-1 (\u03c31) receptor binding: application of the \u201cdeconstruction-reconstruction-elaboration\u201d approach","volume":"5","author":"Glennon","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib24","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1016\/j.bmc.2012.09.044","article-title":"Synthesis of N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamides as new selective ligands for sigma receptors","volume":"20","author":"Marriott","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0960-894X(02)00123-3","article-title":"Synthesis and pharmacological evaluation of 6-piperidino- and 6-piperazinoalkyl-2(3H)-benzothiazolones as mixed \u03c3\/5-HT1A ligands","volume":"12","author":"Mouithys-Mickalad","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.10.053_bib26","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/jm900366z","article-title":"Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for \u03c31 receptor ligands based on a series of substituted benzo[ d ]oxazol-2(3 H )-one Derivatives","volume":"52","author":"Zampieri","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2014.01.013","article-title":"Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands","author":"Donnier-Mar\u00e9chal","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib28","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1016\/j.tet.2008.07.056","article-title":"A\u00a0mild and efficient route to 2-benzyl tryptamine derivatives via ring-opening of \u03b2-carbolines","volume":"64","author":"Hadjaz","year":"2008","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.10.053_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jhet.5570430308","article-title":"Synthesis of 8-substituted tetrahydro-\u03b2-carbolines","volume":"43","author":"Bridoux","year":"2006","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib30","unstructured":"Janssen Pharmaceutica. Benzisoxazoles and phenones as \u03b12-antagonists. Pat. US6576640 B1 (2003)."},{"key":"10.1016\/j.ejmech.2014.10.053_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jhet.5570180630","article-title":"Condensation of 3-methylbenzoxazolinone with a,b-unsaturated acids","volume":"18","author":"Merdji","year":"1981","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(24)38131-5","article-title":"Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line","volume":"289","author":"Ganapathy","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.10.053_bib33","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/jm020889p","article-title":"Novel \u03c3 receptor ligands. Part 2. SAR of spiro[2]benzopyran-1,4\u2032-piperidines] and spiro[[2]benzofuran-1,4\u2032-piperidines] with carbon substituents in position 3","volume":"45","author":"Maier","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib34","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1021\/jm100666w","article-title":"Diaryldiamines with dual inhibition of the histamine H3 receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain","volume":"53","author":"Altenbach","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.053_bib35","doi-asserted-by":"crossref","first-page":"12903","DOI":"10.1016\/j.tet.2007.10.045","article-title":"Synthesis and preliminary evaluation of novel analogues of quindolines as potential stabilisers of telomeric G-quadruplex DNA","volume":"63","author":"Huddleston","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.10.053_bib36","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00706-006-0554-5","article-title":"Conversion of phthalimides to isoindolines by diborane","volume":"137","author":"Awruch","year":"2006","journal-title":"Monatsh. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T06:26:30Z","timestamp":1746426390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414009817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":36,"alternative-id":["S0223523414009817"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.053","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}